Biomarkers of cardiometabolic risk, inflammation and disease

Filipe Palavra; Flávio Reis; Daniela Marado; Armando Sena

doi:10.1007/978-3-319-16018-4

Biomarkers of cardiometabolic risk, inflammation and disease

Filipe Palavra
, Flávio Reis
, Daniela Marado
, Armando Sena

Resultado de pesquisa: ???type-name??? › ???researchoutput.researchoutputtypes.bookanthology.book??? › revisão de pares

1 Citação (Scopus)

Resumo

This book discusses recent advances in the area of cardiometabolic risk biomarkers of chronic inflammatory and cardiovascular disorders. Tackling the topic in a systematic manner, the book starts with an introduction to cardiometabolic risk and its clinical relevance, comparing emergent and classical biomarkers. It then goes on to discuss cardiometabolic risk biomarkers in a range of diseases, including diabetes, ischemic stroke and neurodegenerative disorders."Biomarkers of Cardiometabolic Risk, Inflammation and Disease"is aimed at doctors specializing in internal medicine, neurology, cardiology, rheumatology, nephrology or endocrinology and will also be of interest to GPs, trainee doctors and clinical and basic researchers working on cardiovascular and autoimmune disorders."

Idioma original	???core.languages.en_GB???
Editora	Springer International Publishing
Número de páginas	165
ISBN (eletrónico)	9783319160184
ISBN (impresso)	9783319160177
DOIs	https://doi.org/10.1007/978-3-319-16018-4
Estado da publicação	???researchoutput.status.published??? - 1 jan. 2015

ODS da ONU

Este resultado contribui para o(s) seguinte(s) Objetivo(s) de Desenvolvimento Sustentável

ODS 3 Boa saúde e bem-estar

Acesso ao documento

10.1007/978-3-319-16018-4

Outros arquivos e links

Link to publication in Scopus

Citar isto

@book{7a5ca1e334494aabb132f57338980b74,

title = "Biomarkers of cardiometabolic risk, inflammation and disease",

abstract = "This book discusses recent advances in the area of cardiometabolic risk biomarkers of chronic inflammatory and cardiovascular disorders. Tackling the topic in a systematic manner, the book starts with an introduction to cardiometabolic risk and its clinical relevance, comparing emergent and classical biomarkers. It then goes on to discuss cardiometabolic risk biomarkers in a range of diseases, including diabetes, ischemic stroke and neurodegenerative disorders.{"}Biomarkers of Cardiometabolic Risk, Inflammation and Disease{"}is aimed at doctors specializing in internal medicine, neurology, cardiology, rheumatology, nephrology or endocrinology and will also be of interest to GPs, trainee doctors and clinical and basic researchers working on cardiovascular and autoimmune disorders.{"}",

author = "Filipe Palavra and Fl{\'a}vio Reis and Daniela Marado and Armando Sena",

note = "Publisher Copyright: {\textcopyright} Springer International Publishing Switzerland 2015.",

year = "2015",

month = jan,

day = "1",

doi = "10.1007/978-3-319-16018-4",

language = "English",

isbn = "9783319160177",

publisher = "Springer International Publishing",

}

TY - BOOK

T1 - Biomarkers of cardiometabolic risk, inflammation and disease

AU - Palavra, Filipe

AU - Reis, Flávio

AU - Marado, Daniela

AU - Sena, Armando

PY - 2015/1/1

Y1 - 2015/1/1

N2 - This book discusses recent advances in the area of cardiometabolic risk biomarkers of chronic inflammatory and cardiovascular disorders. Tackling the topic in a systematic manner, the book starts with an introduction to cardiometabolic risk and its clinical relevance, comparing emergent and classical biomarkers. It then goes on to discuss cardiometabolic risk biomarkers in a range of diseases, including diabetes, ischemic stroke and neurodegenerative disorders."Biomarkers of Cardiometabolic Risk, Inflammation and Disease"is aimed at doctors specializing in internal medicine, neurology, cardiology, rheumatology, nephrology or endocrinology and will also be of interest to GPs, trainee doctors and clinical and basic researchers working on cardiovascular and autoimmune disorders."

AB - This book discusses recent advances in the area of cardiometabolic risk biomarkers of chronic inflammatory and cardiovascular disorders. Tackling the topic in a systematic manner, the book starts with an introduction to cardiometabolic risk and its clinical relevance, comparing emergent and classical biomarkers. It then goes on to discuss cardiometabolic risk biomarkers in a range of diseases, including diabetes, ischemic stroke and neurodegenerative disorders."Biomarkers of Cardiometabolic Risk, Inflammation and Disease"is aimed at doctors specializing in internal medicine, neurology, cardiology, rheumatology, nephrology or endocrinology and will also be of interest to GPs, trainee doctors and clinical and basic researchers working on cardiovascular and autoimmune disorders."

UR - https://www.scopus.com/pages/publications/84944044403

U2 - 10.1007/978-3-319-16018-4

DO - 10.1007/978-3-319-16018-4

M3 - Book

AN - SCOPUS:84944044403

SN - 9783319160177

BT - Biomarkers of cardiometabolic risk, inflammation and disease

PB - Springer International Publishing

ER -

Biomarkers of cardiometabolic risk, inflammation and disease

Resumo

ODS da ONU

Acesso ao documento

Outros arquivos e links

Impressão digital

Citar isto